CSF-Dynamics is developing a new type of hydrocephalus shunt that overcomes the major issues of current shunts on the market. The shunt is currently undergoing clinical testing. CSF-Dynamics expects the shunt to be approved for clinical use by Q1, 2025.
Please contact us by email if you are interested to know more about the technology and the status of the development.
CSF-Dynamics has received a Horizon 2020 SME Phase 2 grant (849502) from the European Commission that supports our effort to bring the product to market as soon as possible.
If you are a physician, investor or patient, please contact us to receive a password to enter our website.
Please contact: Tom Markussen, email@example.com